Cargando…
High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma
Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597026/ https://www.ncbi.nlm.nih.gov/pubmed/34505339 http://dx.doi.org/10.1002/anie.202107223 |
_version_ | 1784600520024915968 |
---|---|
author | Liu, Qinlei Ge, Wenjie Wang, Tongtong Lan, Jiayi Martínez‐Jarquín, Sandra Wolfrum, Christian Stoffel, Markus Zenobi, Renato |
author_facet | Liu, Qinlei Ge, Wenjie Wang, Tongtong Lan, Jiayi Martínez‐Jarquín, Sandra Wolfrum, Christian Stoffel, Markus Zenobi, Renato |
author_sort | Liu, Qinlei |
collection | PubMed |
description | Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze multiple metabolites in single cells at a rate of 38 cells/minute. Multiple cell types (HEK‐293T, PANC‐1, CFPAC‐1, H6c7, HeLa and iBAs) were discriminated successfully. We found evidence for abnormal lipid metabolism in pancreatic cancer cells. We also analyzed gene expression in a cancer genome atlas dataset and found that the mRNA level of a critical enzyme of lipid synthesis (ATP citrate lyase, ACLY) was upregulated in human pancreatic ductal adenocarcinoma (PDAC). Moreover, both an ACLY chemical inhibitor and a siRNA approach targeting ACLY could suppress the viability of PDAC cells. A significant reduction in lipid content in treated cells indicates that ACLY could be a potential target for treating pancreatic cancer. |
format | Online Article Text |
id | pubmed-8597026 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85970262021-11-22 High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma Liu, Qinlei Ge, Wenjie Wang, Tongtong Lan, Jiayi Martínez‐Jarquín, Sandra Wolfrum, Christian Stoffel, Markus Zenobi, Renato Angew Chem Int Ed Engl Research Articles Even populations of clonal cells are heterogeneous, which requires high‐throughput analysis methods with single‐cell sensitivity. Here, we propose a rapid, label‐free single‐cell analytical method based on active capillary dielectric barrier discharge ionization mass spectrometry, which can analyze multiple metabolites in single cells at a rate of 38 cells/minute. Multiple cell types (HEK‐293T, PANC‐1, CFPAC‐1, H6c7, HeLa and iBAs) were discriminated successfully. We found evidence for abnormal lipid metabolism in pancreatic cancer cells. We also analyzed gene expression in a cancer genome atlas dataset and found that the mRNA level of a critical enzyme of lipid synthesis (ATP citrate lyase, ACLY) was upregulated in human pancreatic ductal adenocarcinoma (PDAC). Moreover, both an ACLY chemical inhibitor and a siRNA approach targeting ACLY could suppress the viability of PDAC cells. A significant reduction in lipid content in treated cells indicates that ACLY could be a potential target for treating pancreatic cancer. John Wiley and Sons Inc. 2021-10-11 2021-11-08 /pmc/articles/PMC8597026/ /pubmed/34505339 http://dx.doi.org/10.1002/anie.202107223 Text en © 2021 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Liu, Qinlei Ge, Wenjie Wang, Tongtong Lan, Jiayi Martínez‐Jarquín, Sandra Wolfrum, Christian Stoffel, Markus Zenobi, Renato High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title | High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title_full | High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title_fullStr | High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title_full_unstemmed | High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title_short | High‐Throughput Single‐Cell Mass Spectrometry Reveals Abnormal Lipid Metabolism in Pancreatic Ductal Adenocarcinoma |
title_sort | high‐throughput single‐cell mass spectrometry reveals abnormal lipid metabolism in pancreatic ductal adenocarcinoma |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597026/ https://www.ncbi.nlm.nih.gov/pubmed/34505339 http://dx.doi.org/10.1002/anie.202107223 |
work_keys_str_mv | AT liuqinlei highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT gewenjie highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT wangtongtong highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT lanjiayi highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT martinezjarquinsandra highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT wolfrumchristian highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT stoffelmarkus highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma AT zenobirenato highthroughputsinglecellmassspectrometryrevealsabnormallipidmetabolisminpancreaticductaladenocarcinoma |